United States President Donald Trump has unveiled a second deal with a major pharmaceutical company to offer lower-cost prescription drugs direct to American consumers.
This time, the agreement concerned AstraZeneca, a multinational based in the…

United States President Donald Trump has unveiled a second deal with a major pharmaceutical company to offer lower-cost prescription drugs direct to American consumers.
This time, the agreement concerned AstraZeneca, a multinational based in the…